Index Fund Advisors, Inc. Caladrius Biosciences, Inc. Call Options Transaction History

Index Fund Advisors, Inc.

  • $1.83 Billion
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About CALADRIUS BIOSCIENCES, INC.

CLBS Quotes by TradingView
  • Ticker CLBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,583,200
  • Market Cap $25.8M
  • Description
  • Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...
More about CLBS
Track This Portfolio

Track Index Fund Advisors, Inc. Portfolio

Follow Index Fund Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Index Fund Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Index Fund Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email